Efficacy of Paragastric Neural Block Procedure on Postoperative Pain in Patients Who Underwent Sleeve Gastrectomy
Efficacy and Safety of Paragastric Neural Block in Controlling Pain, Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy; Prospective Randomized Controlled Double-blind Study
1 other identifier
interventional
90
1 country
1
Brief Summary
Surgical treatment is the most effective way to achieve effective and sustainable weight loss in patients with obesity and to improve the comorbidities caused by it. Although minimally invasive bariatric surgical procedures are applied today, postoperative pain is one of the most basic problems. Opioid-derived drugs used for pain control cause respiratory depression and constipation. Enhanced Recovery After Surgery (ERAS) protocols recommend reducing opioid use after bariatric surgery to help patients have a healthier postoperative period. Different methods such as transversus abdominis plane (TAP) block and erector spinae plane (ESP) block are used to reduce the postoperative opioid dose and for effective pain control. While these methods are effective in controlling somatic pain, they have no effect on visceral pain. It has been shown that patients' pain and opioid consumption decrease especially after celiac plexus block. Vagal and sympathetic afferent stimuli from the gastrointestinal tract, on the other hand, stimulate the vomiting center and cause nausea and vomiting. Paragastric neural block is a new method performed by injecting local anesthetic into the posterosuperior paragastric area in the area covering the left gastric artery by revealing the esophagogastric junction, proximal stomach, middle of the stomach, distal antrum, hepatoduodenal ligament and stomach posterior along the border of the lesser omentum. In this way, it is aimed to prevent both visceral pain and the symptoms of nausea and vomiting. In our study, the investigators aimed to evaluate the efficacy and safety of paragastric nerve block applied during laparoscopic sleeve gastrectomy by comparing it with the control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started May 2023
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 9, 2023
CompletedFirst Submitted
Initial submission to the registry
July 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedFirst Posted
Study publicly available on registry
August 9, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 10, 2023
CompletedAugust 9, 2023
July 1, 2023
3 months
July 18, 2023
July 31, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Postoperative pain
The investigators used visual analog scale. Minimum value 0 (means no pain), maximum values 10 (means worst pain ever).
In first 24 hours
Postoperative nause and vomiting
The investigators used Post operative nause and vomiting impact scale. Minimum value 0, maximum values 6. Total score \>4 defines clinically important postoperative nause and vomiting.
In first 24 hours
Secondary Outcomes (16)
First Rescue analgesia
In first 24 hours
Second Rescue analgesia
In first 24 hours
Rescue antiemetic
In first 24 hours
Time to rescue antiemetic
In first 24 hours
Time to first rescue analgesia
In first 24 hours
- +11 more secondary outcomes
Study Arms (2)
Paragastric neural block
ACTIVE COMPARATORPatients who were operated for sleeve gastrectomy were included in the study. Afterwards, they were divided into two groups. While pragastric neural block was applied to one group, no intervention was made to the other group.
Control
NO INTERVENTIONControl grup
Interventions
A block method used to control patients' symptoms of pain, nausea and vomiting after surgery.
Eligibility Criteria
You may qualify if:
- Body mass index of over 35 and an obesity-related comorbidity,
- Body mass index of over 40,
- Patients who underwent laparoscopic sleeve gastrectomy,
- ASA risk score of 2-3,
- Agreed to be included in the study.
You may not qualify if:
- Chronic pain disorder or using gabapentin,
- Opioid addicts,
- Using anticoagulant drugs,
- History of previous upper gastrointestinal system surgery,
- Surgical complications during or after surgery,
- Hepatic or renal failure,
- Moderate or severe cardiovascular or respiratory disease,
- Allergy to the local anesthetic agent to be applied for the block,
- Limited cooperation,
- More than one surgical intervention in the same session,
- Allergy to the drugs to be used in the postoperative treatment protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Atlas Universitylead
Study Sites (1)
Atlas university
Istanbul, Turkey (Türkiye)
Related Publications (10)
Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L; NEDCOM, the Netherlands Epidemiology and Demography Compression of Morbidity Research Group. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003 Jan 7;138(1):24-32. doi: 10.7326/0003-4819-138-1-200301070-00008.
PMID: 12513041BACKGROUNDArterburn DE, Olsen MK, Smith VA, Livingston EH, Van Scoyoc L, Yancy WS Jr, Eid G, Weidenbacher H, Maciejewski ML. Association between bariatric surgery and long-term survival. JAMA. 2015 Jan 6;313(1):62-70. doi: 10.1001/jama.2014.16968.
PMID: 25562267BACKGROUNDLiu JJ, Brenner DM. Opioid-Related Constipation. Gastroenterol Clin North Am. 2022 Mar;51(1):107-121. doi: 10.1016/j.gtc.2021.10.007. Epub 2022 Jan 8.
PMID: 35135657BACKGROUNDBudiansky AS, Margarson MP, Eipe N. Acute pain management in morbid obesity - an evidence based clinical update. Surg Obes Relat Dis. 2017 Mar;13(3):523-532. doi: 10.1016/j.soard.2016.09.013. Epub 2016 Sep 19.
PMID: 27771314BACKGROUNDStenberg E, Dos Reis Falcao LF, O'Kane M, Liem R, Pournaras DJ, Salminen P, Urman RD, Wadhwa A, Gustafsson UO, Thorell A. Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update. World J Surg. 2022 Apr;46(4):729-751. doi: 10.1007/s00268-021-06394-9. Epub 2022 Jan 4.
PMID: 34984504BACKGROUNDEmile SH, Abdel-Razik MA, Elbahrawy K, Elshobaky A, Shalaby M, Elbaz SA, Gado WA, Elbanna HG. Impact of Ultrasound-Guided Transversus Abdominis Plane Block on Postoperative Pain and Early Outcome After Laparoscopic Bariatric Surgery: a Randomized Double-Blinded Controlled Trial. Obes Surg. 2019 May;29(5):1534-1541. doi: 10.1007/s11695-019-03720-y.
PMID: 30706309BACKGROUNDZengin SU, Ergun MO, Gunal O. Effect of Ultrasound-Guided Erector Spinae Plane Block on Postoperative Pain and Intraoperative Opioid Consumption in Bariatric Surgery. Obes Surg. 2021 Dec;31(12):5176-5182. doi: 10.1007/s11695-021-05681-7. Epub 2021 Aug 27.
PMID: 34449029BACKGROUNDDaes J, Morrell DJ, Hanssen A, Caballero M, Luque E, Pantoja R, Luquetta J, Pauli EM. Paragastric Autonomic Neural Blockade to Prevent Early Visceral Pain and Associated Symptoms After Laparoscopic Sleeve Gastrectomy: a Randomized Clinical Trial. Obes Surg. 2022 Nov;32(11):3551-3560. doi: 10.1007/s11695-022-06257-9. Epub 2022 Sep 2.
PMID: 36050617BACKGROUNDKambadakone A, Thabet A, Gervais DA, Mueller PR, Arellano RS. CT-guided celiac plexus neurolysis: a review of anatomy, indications, technique, and tips for successful treatment. Radiographics. 2011 Oct;31(6):1599-621. doi: 10.1148/rg.316115526.
PMID: 21997984BACKGROUNDRana MV, Candido KD, Raja O, Knezevic NN. Celiac plexus block in the management of chronic abdominal pain. Curr Pain Headache Rep. 2014 Feb;18(2):394. doi: 10.1007/s11916-013-0394-z.
PMID: 24414338BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mehmet K Katar, Assoc.Prof.
Atlas University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Randomization was performed by a general surgeon who would not be present during the block procedure. Patients were numbered sequentially according to the randomization scheme. Patient numbers were recorded in the follow-up files. Evaluation of the postoperative results was done by a general surgeon who was unaware of the group distributions. Since both the patients and the general surgeon who will make the evaluation did not know whether the block procedure was applied or not, the study was performed as double-blind.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 18, 2023
First Posted
August 9, 2023
Study Start
May 9, 2023
Primary Completion
August 1, 2023
Study Completion
August 10, 2023
Last Updated
August 9, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Start after the publication.
- Access Criteria
- All results of working can be shared with researchers after the study is published.
Data will be shared after the article is published.